Brain tumor study looks at tiny molecule as possible clue
NCT ID NCT01849952
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study looked at a tiny molecule called microRNA-10b in people with brain tumors called gliomas. Researchers wanted to see if higher levels of this molecule could help predict how the disease might progress or how long patients might live. The study was stopped early, but it aimed to better understand different types of gliomas and possibly find new ways to treat them.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANAPLASTIC ASTROCYTOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire, 03756, United States
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
-
Tufts Medical Center
Boston, Massachusetts, 02111, United States
-
University of Vermont
Burlington, Vermont, 05405, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New imaging clues could sharpen brain tumor monitoring
- Can a virus injected into brain tumors fight recurrence?
- Can a Tumor's genetic blueprint guide better treatment for kids with brain cancer?
- Can a seizure drug outsmart a deadly brain tumor?
- Can adding lenvatinib to standard care outsmart a tough brain cancer?
- A simple lotion duo may shield skin from Tumor-Treating fields